Status:

RECRUITING

VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024

Lead Sponsor:

Centre Hospitalier Sud Francilien

Conditions:

Pneumonia Ventilator Associated

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this observational study is to to analyze respiratory samples performed in mechanically ventilated ICU patients and to assess whether the SRLF criteria for defining VAP were respected amon...

Detailed Description

Ventilator-associated pneumonia (VAP) is a lung infection that occurs after more than 48 hours of mechanical ventilation. It is of particular interest because it affects between 5-40% of ICU patients ...

Eligibility Criteria

Inclusion

  • Adults ≥ 18 years
  • Hospitalization in Intensive care unit for the period between 01/01/2022 and 31/12/2024
  • Intubation and mechanical ventilation for \> 48h
  • Positive respiratory sample

Exclusion

  • Decision of therapeutic limitation
  • Organ donors
  • Patient refuse to participate

Key Trial Info

Start Date :

August 25 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT07181824

Start Date

August 25 2025

End Date

June 30 2026

Last Update

December 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, France, France, 91100

VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024 | DecenTrialz